BeStock  
Stocks › Biotechnology › RXRX

Recursion Pharmaceuticals RXRX

US equityMarket cap rank #2603BiotechnologyAI medical concept stocks
$4.78 +$0.66 (+16.02%)
Pre-market · Oct 6, 4:10 am ET · After hours $4.76 -0.42%
Open$4.16
Prev close$4.12
Day range$4.06 – $4.94
Volume67.28M
Market cap$2.56B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership67.6%-5.14 pts vs. prior quarter
Institutions holding388-1 vs. prior quarter
Insider trades (recent)9 buys / 41 sellsNet selling
Short interest33.39% of floatDays to cover 12.6 · as of 15 Sep 2026
Short-sale volume share20.8%5-day average of daily volume

Short-sale volume as % of daily volume

18%21%24%27%Sep '26Sep '26Oct '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$1.37M (11 inflow days, 9 outflow days).

The five largest holders on file together own 34.3% of shares outstanding.

Largest holders

  • BlackRock9.38%
  • ARK Investment Management LLC7.71%
  • State Street Global Advisors6.47%
  • Vanguard Portfolio Management, LLC5.81%
  • Vanguard Capital Management, LLC4.89%
  • Baillie Gifford4.38%
  • Geode Capital Management, LLC2.58%
  • SoftBank Group Corp.2.54%

By investor type

  • Mutual Fund52.35%
  • VC/PE Fund4.59%
  • Public Company4.44%
  • Individual/Insider2.98%
  • Hedge Fund2.91%
  • Sovereign Wealth Fund1.27%
  • Private Company1.12%
  • Family Office/Trust0.48%

Reported short interest has risen from 32.52% to 33.39% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Short interest, by report

Report dateShares short% of floatDays to cover
15 Sep 2026 178,724,433 33.4% 12.6
31 Aug 2026 179,145,796 33.5% 10.6
14 Aug 2026 177,923,359 33.2% 13.4
31 Jul 2026 180,771,459 34.1% 9.3
15 Jul 2026 180,760,541 34.1% 6.7
30 Jun 2026 172,302,180 32.5% 8.4

Discussion

No comments yet — be the first to weigh in on RXRX.

Leave a comment

Scroll to Top